Publication | Open Access
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer
14
Citations
20
References
2021
Year
TrkB/BDNF signaling may be a new therapeutic target for PDAC. Therapies targeting TrkB/BDNF signaling may be a conclusive cancer therapy for refractory solid cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1